Altium Capital Management »

Ascendis Pharma A S shares owned by Altium Capital Management

Quarter-by-quarter ownership of Ascendis Pharma A S (ASND) shares owned by Altium Capital Management from 13F filings

Historical chart of Altium Capital Management investment in Ascendis Pharma A S

Tip: Access up to 7 years of quarterly data

All positions including Ascendis Pharma A S held by Altium Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ascendis Pharma A S by Altium Capital Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $6.8M 50k 136.38
2024-03-31 $3.8M 25k 151.17

More positions owned by Altium Capital Management

Vera Therapeutics Cl A (VERA)
Adma Biologics (ADMA)
Xenon Pharmaceuticals (XENE)
Intra Cellular Therapies (ITCI)
Sarepta Therapeutics (SRPT)
Insmed Com Par $.01 (INSM)
Alimera Sciences Com New
Skye Bioscience Com New (SKYE)
Argenx Se Sponsored Adr (ARGX)
Soleno Therapeutics (SLNO)
Avadel Pharmaceuticals Com Shs (AVDL)
Catalyst Pharmaceutical Partners (CPRX)
Contineum Therapeutics Cl A (CTNM)
Rezolute Com New (RZLT)
Ascendis Pharma A/s Sponsored Adr (ASND)

View all positions for Altium Capital Management

Top funds holding Ascendis Pharma A S

RA Capital Management
Westfield Capital Management Company
Artisan Partners Limited Partnership
Henderson Group
T. Rowe Price Associates
Capital Research and Management Company - Division 3
Massachusetts Financial Services
T. Rowe Price Investment Management
Franklin Resources
Invesco
Citadel Advisors
BlackRock
Point72 Asset Management
TimesSquare Capital Management
Brown Advisory Holdings Incorporated

View all funds holding Ascendis Pharma A S